Apellis Pharmaceuticals, Inc. (APLS)

27.30 +1.04 (+3.98%) USD  |  NASDAQ  |  Jan 09, 16:00
27.25 -0.06 (-0.20%) After-Hours: 17:52
More

Apellis Pharmaceuticals Long Term Deferred Charges (Quarterly)

Long Term Deferred Charges (Quarterly) Chart

View Long Term Deferred Charges (Quarterly) for APLS.
Upgrade now.
Sep '18
Jan '19
May '19
 
285.00
270.00
255.00
240.00
View Long Term Deferred Charges (Quarterly) Chart
Start Trial

Historical Data

View Historical Data
Start Trial

Long Term Deferred Charges (Quarterly) Range, Past 5 Years

View Long Term Deferred Charges (Quarterly) Range, Past 5 Years
Start Trial
--
Minimum
--
Maximum
--
Average
--
Median

Long Term Deferred Charges (Quarterly) Benchmarks

View Long Term Deferred Charges (Quarterly) Benchmarks
Start Trial
Biogen, Inc. --
Amicus Therapeutics, Inc. --
Fortress Biotech, Inc. --
Ultragenyx Pharmaceutical, Inc. --
Fulcrum Therapeutics, Inc. --